Wrong Rx for the FDA
Wednesday, March 7, 2012 - 16:31
in Health & Medicine
Proposed legislation does nothing concrete to lift regulatory obstacles for drug developers and disincentives for potential investors. It allocates $50 million for activities already underway.The congressional legislators who oversee the Food and Drug Administration and control the nation's coffers have shown again that they neither understand drug development nor the regulatory problems that plague it.